Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Linda Kaplan who wrote (5525)	9/8/1998 1:41:00 PM
From: Tokyo VD	Read Replies (1) \| Respond to of 7041

Linda, I'm wondering if you have any insight into Vasomax's Mexican sales? The IMS data is available for July, but Zonagen's Wall Street analysts haven't written about its ability to maintain its percentage of the MED market. Tokyo

To: Linda Kaplan who wrote (5525)	9/8/1998 1:42:00 PM
From: Brander	Read Replies (1) \| Respond to of 7041

"Do you have any concrete examples with which to argue with that reasoning?" Do you have any concrete examples with which to support your reasoning? The point is, it is all speculation at this point. I don't think you or anyone can say how Vasomax will be handled in the UK, if it is even accepted. BTW, I agree 100% with the UK position on Viagra--it should be used only for those with a medical need. I really don't think restricted is the most accurate word here. I think 'apppropriate' use is more accurate. Am I long on ZONA? I don't have any position in ZONA, as I have said before, and I don't plan on taking a position in ZONA; I'm fully vested in speculative stocks. It wouldn't matter anyway, because, whether long or short, I'm interested in the true story, not hype. I do remain long on Pfizer, which is one of my core holdings. Brad